Bulletin
Investor Alert

Gilead Sciences Inc.

NAS: GILD

GO
/marketstate/country/us

After Hours

/zigman2/quotes/210293917/composite

$

77.65

Change

0.00 0.00%

Volume

Volume 319,574

Dec 1, 2023, 5:50 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/210293917/composite

Today's close

$ 76.60

$ 77.65

Change

+1.05 +1.37%

Day low

Day high

$76.20

$77.66

Open
Open: 76.78

52 week low

52 week high

$72.87

$89.74

Open

Market cap

$95.45B

Average volume

5.73M

P/E ratio

16.65

Rev. per Employee

$1.60M

EPS

4.66

Dividend

0.75

Div yield

3.86%

Ex dividend date

12/14/23

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/gild

MarketWatch News on GILD

  1. Disney, Uber, and More to Watch This Week

    8:06 p.m. Nov. 5, 2023

    - Nicholas Jasinski

  2. Stocks Poised to Open Higher

    6:29 p.m. Nov. 5, 2023

    - Janet H. Cho

  3. 3 Reasons High Dividend-Paying Stocks Can Rebound

    2:50 p.m. Oct. 27, 2023

    - Teresa Rivas

  4. Will Obesity Drugs Break the Healthcare System?

    9:16 a.m. Sept. 21, 2023

    - Josh Nathan-Kazis

  5. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/gild

Other News on GILD

  1. S&P 500, Nasdaq Extend Win Streaks

    2:34 a.m. Nov. 9, 2023

    - The Wall Street Journal Interactive Edition

  2. ‘Guided Missile Drugs’ Could Be Big Pharma’s Secret Weapon

    1:32 a.m. Oct. 27, 2023

    - The Wall Street Journal Interactive Edition

  3. Pfizer Looks for a Covid Bottom

    1:33 a.m. Oct. 18, 2023

    - The Wall Street Journal Interactive Edition

  4. This Cancer Therapy is Lifesaving, but There Isn’t Enough of It

    1:33 a.m. Sept. 22, 2023

    - The Wall Street Journal Interactive Edition

  5. The Brash Strategy That Made Vivek Ramaswamy a Fortune

    7:01 a.m. Sept. 18, 2023

    - The Wall Street Journal Interactive Edition

  6. Gilead Sciences Is the Target of a Bizarre Legal Theory

    9:34 a.m. Aug. 20, 2023

    - The Wall Street Journal Interactive Edition

  7. Gilead Sciences Defeats the CDC

    1:34 a.m. May 11, 2023

    - The Wall Street Journal Interactive Edition

  8. 10-Q: GILEAD SCIENCES, INC.

    3:10 p.m. May 3, 2023

    - Edgar Online - (EDG = 10Q, 10K)

  9. These Drugs Are So Futuristic That Doctors Need New Training

    1:32 a.m. April 13, 2023

    - The Wall Street Journal Interactive Edition

  10. Higher Rates Are Coming for U.S. Companies

    1:34 a.m. March 29, 2023

    - The Wall Street Journal Interactive Edition

  11. First Drugs Facing Medicare Price Penalty Are Named

    2:57 a.m. March 16, 2023

    - The Wall Street Journal Interactive Edition

  12. Seagen’s Cancer Therapy Is Making It a Takeover Target

    7:44 a.m. June 5, 2023

    - The Wall Street Journal Interactive Edition

  13. 10-K: GILEAD SCIENCES, INC.

    4:30 p.m. Feb. 22, 2023

    - Edgar Online - (EDG = 10Q, 10K)

  14. AQR CAPITAL MANAGEMENT LLC Buys 3, Sells 2 in 4th Quarter

    10:00 p.m. Feb. 17, 2023

    - GuruFocus.com

  15. VALUEWORKS LLC Buys 1, Sells 4 in 4th Quarter

    8:00 p.m. Feb. 17, 2023

    - GuruFocus.com

  16. Top 5 4th Quarter Trades of HealthInvest Partners AB

    6:00 p.m. Feb. 17, 2023

    - GuruFocus.com

  17. Top 5 4th Quarter Trades of Nan Shan Life Insurance Co., Ltd.

    2:00 p.m. Feb. 16, 2023

    - GuruFocus.com

  18. Top 5 4th Quarter Trades of Avalon Investment & Advisory

    2:00 a.m. Feb. 15, 2023

    - GuruFocus.com

  19. Caxton Associates Buys 4, Sells 1 in 4th Quarter

    6:00 p.m. Feb. 14, 2023

    - GuruFocus.com

  20. Loading more headlines...
/news/pressrelease/company/us/gild

Press Releases on GILD

Rates »

Link to MarketWatch's Slice.